Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics Aug 6, 2025 07:33AM
BridgeBio Oncology Therapeutics to go Public via Merger with Helix Acquisition Cp II (HLXB) Feb 28, 2025 07:50AM
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Tar Feb 28, 2025 07:49AM